15-58542542-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000236.3(LIPC):​c.465G>T​(p.Val155Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.564 in 1,605,242 control chromosomes in the GnomAD database, including 260,334 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.55 ( 23085 hom., cov: 32)
Exomes 𝑓: 0.57 ( 237249 hom. )

Consequence

LIPC
NM_000236.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.134

Publications

43 publications found
Variant links:
Genes affected
LIPC (HGNC:6619): (lipase C, hepatic type) Enables phospholipase A1 activity and triglyceride lipase activity. Involved in several processes, including lipid homeostasis; plasma lipoprotein particle remodeling; and triglyceride catabolic process. Located in extracellular space. Implicated in several diseases, including Alzheimer's disease; coronary artery disease; familial combined hyperlipidemia; peripheral vascular disease; and type 2 diabetes mellitus. Biomarker of hyperinsulinism; obesity; and type 1 diabetes mellitus. [provided by Alliance of Genome Resources, Apr 2022]
LIPC Gene-Disease associations (from GenCC):
  • hyperlipidemia due to hepatic triglyceride lipase deficiency
    Inheritance: AR, Unknown Classification: STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 15-58542542-G-T is Benign according to our data. Variant chr15-58542542-G-T is described in ClinVar as Benign. ClinVar VariationId is 316660.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.134 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.577 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LIPCNM_000236.3 linkc.465G>T p.Val155Val synonymous_variant Exon 4 of 9 ENST00000299022.10 NP_000227.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LIPCENST00000299022.10 linkc.465G>T p.Val155Val synonymous_variant Exon 4 of 9 1 NM_000236.3 ENSP00000299022.5

Frequencies

GnomAD3 genomes
AF:
0.547
AC:
83070
AN:
151864
Hom.:
23081
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.548
Gnomad AMI
AF:
0.729
Gnomad AMR
AF:
0.472
Gnomad ASJ
AF:
0.572
Gnomad EAS
AF:
0.252
Gnomad SAS
AF:
0.566
Gnomad FIN
AF:
0.547
Gnomad MID
AF:
0.525
Gnomad NFE
AF:
0.582
Gnomad OTH
AF:
0.511
GnomAD2 exomes
AF:
0.533
AC:
133986
AN:
251454
AF XY:
0.542
show subpopulations
Gnomad AFR exome
AF:
0.558
Gnomad AMR exome
AF:
0.423
Gnomad ASJ exome
AF:
0.589
Gnomad EAS exome
AF:
0.247
Gnomad FIN exome
AF:
0.556
Gnomad NFE exome
AF:
0.586
Gnomad OTH exome
AF:
0.542
GnomAD4 exome
AF:
0.566
AC:
822296
AN:
1453260
Hom.:
237249
Cov.:
30
AF XY:
0.567
AC XY:
409954
AN XY:
723418
show subpopulations
African (AFR)
AF:
0.544
AC:
18117
AN:
33284
American (AMR)
AF:
0.427
AC:
19093
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.591
AC:
15411
AN:
26078
East Asian (EAS)
AF:
0.218
AC:
8649
AN:
39620
South Asian (SAS)
AF:
0.582
AC:
50102
AN:
86078
European-Finnish (FIN)
AF:
0.552
AC:
29402
AN:
53284
Middle Eastern (MID)
AF:
0.569
AC:
3268
AN:
5748
European-Non Finnish (NFE)
AF:
0.584
AC:
645200
AN:
1104414
Other (OTH)
AF:
0.550
AC:
33054
AN:
60068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
16482
32963
49445
65926
82408
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17550
35100
52650
70200
87750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.547
AC:
83109
AN:
151982
Hom.:
23085
Cov.:
32
AF XY:
0.543
AC XY:
40309
AN XY:
74280
show subpopulations
African (AFR)
AF:
0.548
AC:
22720
AN:
41442
American (AMR)
AF:
0.471
AC:
7203
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.572
AC:
1986
AN:
3470
East Asian (EAS)
AF:
0.252
AC:
1301
AN:
5160
South Asian (SAS)
AF:
0.566
AC:
2723
AN:
4812
European-Finnish (FIN)
AF:
0.547
AC:
5779
AN:
10564
Middle Eastern (MID)
AF:
0.531
AC:
156
AN:
294
European-Non Finnish (NFE)
AF:
0.582
AC:
39513
AN:
67944
Other (OTH)
AF:
0.506
AC:
1063
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1946
3892
5838
7784
9730
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
728
1456
2184
2912
3640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.568
Hom.:
54280
Bravo
AF:
0.542
Asia WGS
AF:
0.352
AC:
1227
AN:
3478
EpiCase
AF:
0.596
EpiControl
AF:
0.589

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Aug 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Hyperlipidemia due to hepatic triglyceride lipase deficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.38
DANN
Benign
0.56
PhyloP100
-0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs690; hg19: chr15-58834741; COSMIC: COSV54420205; API